✦ LIBER ✦

Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment

✍ Scribed by Davis, T. M. E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of renal impairment on the pharma

✍ U. Graefe-Mody; C. Friedrich; A. Port; A. Ring; S. Retlich; T. Heise; A. Halabi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

Efficacy and Safety of Dipeptidyl Peptid

✍ Park, H.; Park, C.; Kim, Y.; Rascati, K. L. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 558 KB

Long-term safety, tolerability, and effi

✍ Masato Odawara; Takashi Kadowaki; Naoko Tajima; Mikio Nishii; Tadaaki Taniguchi; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 377 KB

PDB3 EFFICACY AND SAFETY OF DIPEPTIDYL-P

✍ H Park; YA Kim; KL Rascati 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Dipeptidyl peptidase-4 inhibitors for th

✍ Deacon, Carolyn F; Holst, Jens J 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 419 KB

Safety, Tolerability, Pharmacokinetics,

✍ Hüttner, S.; Graefe-Mody, E. U.; Withopf, B.; Ring, A.; Dugi, K. A. 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 217 KB